by Staff Writers
Paris, France (ESA) Nov 16, 2011
ESA has begun developing a new blood-testing device for astronauts on the International Space Station. A wide range of ailments from diabetes to heart disease should be diagnosable in moments from a single drop of astronaut blood.
A pinprick of blood is added to a mini-disc embedded with a wide variety of miniaturised test procedures. The disc is then inserted into the 'point-of-care' device and set spinning to spread the blood sample across the surface. Multiple tests are performed simultaneously, with automated results delivered within a matter of minutes.
Testing for conditions including diabetes, heart disease, liver and kidney damage, it promises to perform some of the billion or so blood tests ordered by care providers annually to a laboratory level of accuracy in a faster, on-the-spot fashion.
ESA is now looking to adapt the device for space, signing a contract with Irish company Radisens Diagnostics on 28 October. Additional tests will be added and the design developed for the space environment, such ensuring its spinning technique works satisfactorily in weightlessness.
"Biochemical analysis aboard the Space Station is becoming a high priority for the human physiology experiments carried out there," explained Nadine Fritz of ESA's Directorate of Human Spaceflight and Operations.
"The retirement of the Space Shuttle has significantly reduced the amount of cargo we can download from the Station, so it makes sense to do what analysis we can do in orbit."
Ireland's Minister for Research and Innovation Sean Sherlock welcomed the contract: "Radisens Diagnostics' success is the most recent example of an Irish company reaping significant benefits from Ireland's membership of ESA.
"It is encouraging to see that Irish small-to-medium-sized enterprises are developing a profile as providers of innovative solutions for use in the European space programme."
Technology meeting the market
In particular, the contract has come about through a dedicated scheme within the main programme: 'GSTP-AO' targets the development of market-oriented technologies, funded equally by ESA and the partner company.
Companies within participating ESA Member States are free to submit proposals at any time.
"This contract with Radisens demonstrates the flexibility and business reach of this scheme," commented Alberto Tobias, head of ESA's Systems, Software and Technology Department.
"It provides the framework to conduct space 'spin-in' as well as 'spin-out' and joint research with partner sectors, and the processes will be better tuned to facilitate open innovation."
"Winning this contract from ESA is a significant endorsement of our 'sample-to-answer' device and the breadth of blood tests it can offer," said Jerry O'Brien, CEO of Radisens Diagnostics.
"We are delighted to formalise our strategic partnership with ESA with the support of Enterprise Ireland and look forward to working on the application of our technology to terrestrial and space healthcare diagnostic needs."
Space for Health at ESA
Space Medicine Technology and Systems
Comment on this article via your Facebook, Yahoo, AOL, Hotmail login.
Preparing to Stock the Medicine Cabinet for Long-Duration Missions
Houston TX (SPX) Nov 09, 2011
When aerospace engineers design the new vehicle intended for long-duration space travel, they will need to include a good-sized medicine cabinet. Stocking it, however, is more of a challenge than a quick run to the pharmacy, according to results published from the Stability of Pharmacotherapeutic and Nutritional Compounds, or Stability, investigation. This study, which explored pharmaceuti ... read more
|The content herein, unless otherwise known to be public domain, are Copyright 1995-2011 - Space Media Network. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement|